Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma

Human Pathology

Volumn 42, Issue 4, 2011, Pages 552-557

  Richendollar, Bill G ^a   Pohlman, Brad ^a   Elson, Paul ^a   Hsi, Eric D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Follicular lymphoma; PD 1; Prognostic factors

Indexed keywords

CD68 ANTIGEN; PROGRAMMED DEATH 1 LIGAND 1; RITUXIMAB; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGE; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; CANCER RISK; CELL COUNT; FEMALE; FOLLICULAR LYMPHOMA; HELPER CELL; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; RISK FACTOR; SCORING SYSTEM; SEX; STAINING; SYMPTOM; TISSUE SECTION; TUMOR MICROENVIRONMENT;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; APOPTOSIS REGULATORY PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHOCYTES, TUMOR-INFILTRATING; LYMPHOMA, FOLLICULAR; MACROPHAGES; MALE; MIDDLE AGED; PROGNOSIS; PROGRAMMED CELL DEATH 1 RECEPTOR; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT; YOUNG ADULT;

EID: 79952984773     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.08.015     Document Type: Article

References (29)

1. Johnson P.W., Rohatiner A.Z., and Whelan J.S. Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center J Clin Oncol 13 1995 140 147
2. Solal-Céligny P., Roy P., and Colombat P. Follicular lymphoma international prognostic index Blood 104 2004 1258 1265 (Pubitemid 39166497)
3. Federico M., Bellei M., and Marcheselli L. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project J Clin Oncol 27 2009 4555 4562
4. Dave S.S., Wright G., and Tan B. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells N Engl J Med 351 2004 2159 2169 (Pubitemid 39507628)
5. + cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome J Clin Oncol 24 2006 5052 5059 (Pubitemid 46631409)
6. Glas A.M., Knoops L., and Delahaye L. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma J Clin Oncol 25 2007 390 398 (Pubitemid 350002987)
7. + T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma Clin Cancer Res 13 2007 388 397 (Pubitemid 46225341)
8. Alvaro T., Lejeune M., and Salvadó M.T. Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients J Clin Oncol 24 2006 5350 5357 (Pubitemid 46623165)
9. Farinha P., Masoudi H., and Skinnider B.F. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL) Blood 106 2005 2169 2174 (Pubitemid 41291735)
10. Kelley T., Beck R., Absi A., Jin T., Pohlman B., and Hsi E. Biologic predictors in follicular lymphoma: importance of markers of immune response Leuk Lymphoma 48 2007 2403 2411 (Pubitemid 350253472)
11. Carreras J., Lopez-Guillermo A., and Fox B.C. High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma Blood 108 2006 Nov 2957 2964
12. Keir M.E., Butte M.J., Freeman G.J., and Sharpe A.H. PD-1 and its ligands in tolerance and immunity Annu Rev Immunol 26 2008 677 704 (Pubitemid 351600389)
13. Riley J.L. PD-1 signaling in primary T cells Immunol Rev 229 2009 114 125
14. Fife B.T., and Bluestone J.A. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways Immunol Rev 224 2008 166 182
15. Iwai Y., Terawaki S., and Honjo T. PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells Int Immunol 17 2005 133 144 (Pubitemid 40246578)
16. Blank C., Kuball J., and Voelkl S. Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro Int J Cancer 119 2006 Jul 15 317 327
17. Thompson R.H., Kuntz S.M., and Leibovich B.C. Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up Cancer Res 66 2006 3381 3385
18. Wu C., Zhu Y., Jiang J., Zhao J., Zhang X.G., and Xu N. Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance Acta Histochem 108 2006 19 24 (Pubitemid 44316588)
19. Ghebeh H., Mohammed S., and Al-Omair A. The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors Neoplasia 8 2006 190 198 (Pubitemid 43671234)
20. Ohigashi Y., Sho M., and Yamada Y. Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer Clin Cancer Res 11 2005 2947 2953 (Pubitemid 40525197)
21. Dorfman D.M., Brown J.A., Shahsafaei A., and Freeman G.J. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma Am J Surg Pathol 30 2006 802 810 (Pubitemid 44264969)
22. Michels J., Foria V., and Mead B. Immunohistochemical analysis of the antiapoptotic Mcl-1 and Bcl-2 proteins in follicular lymphoma Br J Haematol 132 2006 743 746 (Pubitemid 43381636)
23. Llanos M., Alvarez-Argüelles H., Alemán R., Oramas J., Diaz-Flores L., and Batista N. Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma Med Oncol 18 2001 15 22 (Pubitemid 32906732)
24. Pezzella F., Jones M., Ralfkiaer E., Ersbøll J., Gatter K.C., and Mason D.Y. Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma Br J Cancer 65 1992 87 89
25. Yamamoto R., Nishikori M., and Kitawaki T. PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma Blood 111 2008 3220 3224
26. Brown J.A., Dorfman D.M., and Ma F.R. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production J Immunol 170 2003 1257 1266 (Pubitemid 36139491)
27. Carreras J., Lopez-Guillermo A., and Roncador G. High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma J Clin Oncol 27 2009 1470 1476
28. + T cell density and architectural patterns predict overall survival and risk of transformation in uniformly treated patients with follicular lymphoma Blood (ASH Annual Meeting Abstracts) 112 2008 2815
29. Wahlin B.E., Aggarwal M., and Montes-Moreno S. A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1-positive, regulatory, cytotoxic, and helper T cells and macrophages Clin Cancer Res 16 2010 637 650